{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Miami",
      "state": "FL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65383",
      "recalling_firm": "Dolphin Intertrade Corporation",
      "address_1": "11314 Sw 135th Ct",
      "address_2": "N/A",
      "postal_code": "33186-4425",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1249-2014",
      "product_description": "JaDera, 100% Natural Weight Loss Supplement, capsules,  30 count bottle",
      "product_quantity": "998 boxes",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.",
      "recall_initiation_date": "20130520",
      "center_classification_date": "20140418",
      "termination_date": "20160629",
      "report_date": "20140430",
      "code_info": "Manufacturing Codes:  10.06.2011 Exp. 09.06.2013",
      "more_code_info": ""
    }
  ]
}